HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 13.45 CNY 0.75% Market Closed
Market Cap: 5.4B CNY
Have any thoughts about
HitGen Inc?
Write Note

HitGen Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HitGen Inc
Research & Development Peer Comparison

Comparables:
603259
300759
2269
300347
W
2268

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
HitGen Inc
SSE:688222
Research & Development
-ÂĄ70.5m
CAGR 3-Years
9%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Research & Development
-ÂĄ1.4B
CAGR 3-Years
-23%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Research & Development
-ÂĄ473.9m
CAGR 3-Years
-55%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Research & Development
-ÂĄ788.4m
CAGR 3-Years
-39%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Research & Development
-ÂĄ258.2m
CAGR 3-Years
-13%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Research & Development
-ÂĄ76.9m
CAGR 3-Years
-166%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is HitGen Inc's Research & Development?
Research & Development
-70.5m CNY

Based on the financial report for Dec 31, 2023, HitGen Inc's Research & Development amounts to -70.5m CNY.

What is HitGen Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-3%

Over the last year, the Research & Development growth was 8%. The average annual Research & Development growth rates for HitGen Inc have been 9% over the past three years , -3% over the past five years .

Back to Top